Biological imaging in radiation therapy: Role of positron emission tomography

Physics in Medicine and Biology

Volumn 54, Issue 1, 2009, Pages

  Nestle, Ursula ^a   Weber, Wolfgang ^a   Hentschel, Michael ^a   Grosu, Anca Ligia ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; AMINO ACIDS; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC RADIOGRAPHY; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; OPTOELECTRONIC DEVICES; ORGANIC ACIDS; POSITRON ANNIHILATION SPECTROSCOPY; POSITRONS; RADIOTHERAPY; TOMOGRAPHY; TUMORS;

ANATOMICAL IMAGING; BIOLOGICAL IMAGING; BIOLOGICAL PROCESSES; CLINICAL OUTCOMES; COMPUTED TOMOGRAPHIES; COST/BENEFIT ANALYSIS; FLUORODEOXYGLUCOSE; HEAD AND NECKS; HIGH RESOLUTIONS; METABOLIC PATHWAYS; POSITRON EMISSIONS; RADIATION THERAPIES; TARGET VOLUME DELINEATIONS; TREATMENT PLANNING; TUMOUR TISSUES;

POSITRON EMISSION TOMOGRAPHY;

3' FLUOROTHYMIDINE F 18; AMINO ACID; ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; IODINE 123; METHIONINE;

BRAIN; BREATHING MECHANICS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL PROLIFERATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DRUG UPTAKE; GLIOMA; HEAD AND NECK CANCER; HUMAN; HYPOXIA; IMAGE PROCESSING; INTENSITY MODULATED RADIATION THERAPY; LUNG CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE DISTRIBUTION; REVIEW; TREATMENT PLANNING; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR VOLUME;

ANOXIA; CELL PROLIFERATION; HUMANS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY; TUMOR BURDEN;

EID: 58149280395     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/54/1/R01     Document Type: Review

References (142)

1. Abouzied M M, Crawford E S and Nabi H A 2005 18F-FDG imaging: pitfalls and artifacts J. Nucl. Med. Technol. 33 145-55 quiz 162-3
2. Alber M, Paulsen F, Eschmann S M and Machulla H J 2003 On biologically conformal boost dose optimization Phys. Med. Biol. 48 N31-5
3. Baum R P, Hellwig D and Mezzetti M 2004 Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer Q J. Nucl. Med. Mol. Imaging 48 119-42
4. Bayne M, MacManus M, Hicks R, Leong T, Peters L and Ball D 2005 Can a mathematical formula help define a radiation target volume using positron emission tomography? In regard to Black et al 2004 (Int. J. Radiat. Oncol. Biol. Phys. 60 1272-1282) Int. J. Radiat. Oncol. Biol. Phys. 62 299-300 author reply 300
5. Beer A J et al 2006 Positron emission tomography using [18F]galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man Clin. Cancer Res. 12 3942-9
6. Bentzen S M 2005 Radiation therapy: intensity modulated, image guided, biologically optimized and evidence based Radiother. Oncol. 77 227-30
7. Beyer T, Antoch G, Blodgett T, Freudenberg L F, Akhurst T and Mueller S 2003 Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology Eur. J. Nucl. Med. Mol. Imaging 30 588-96
8. Beyer T et al 2005 Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows Eur. J. Nucl. Med. Mol. Imaging 32 1429-39
9. Black Q C, Grills I S, Kestin L L, Wong C Y, Wong J W, Martinez A A and Yan D 2004 Defining a radiotherapy target with positron emission tomography Int. J. Radiat. Oncol. Biol. Phys. 60 1272-82
10. Boellaard R, Krak N C, Hoekstra O S and Lammertsma A A 2004 Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study J. Nucl. Med. 45 1519-27
11. Bortfeld T, Jiang S B and Rietzel E 2004 Effects of motion on the total dose distribution Semin. Radiat. Oncol. 14 41-51
12. Bradley J, Thorstad W L, Mutic S, Miller T R, Dehdashti F, Siegel B A, Bosch W and Bertrand R J 2004 Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int. J. Radiat. Oncol. Biol. Phys. 59 78-86
13. Buck A K et al 2005 Clinical relevance of imaging proliferative activity in lung nodules Eur. J. Nucl. Med. Mol. Imaging 32 525-33
14. Bussink J, Kaanders J H and van der Kogel A J 2003 Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers Radiother. Oncol. 67 3-15
15. Caldwell C B, Mah K, Skinner M and Danjoux C E 2003 Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET Int. J. Radiat. Oncol. Biol. Phys. 55 1381-93
16. Caldwell C B, Mah K, Ung Y C, Danjoux C E, Balogh J M, Ganguli S N and Ehrlich L E 2001 Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion Int. J. Radiat. Oncol. Biol. Phys. 51 923-31
17. Chan S C, Ng S H, Chang J T, Lin C Y, Chen Y C, Chang Y C, Hsu C L, Wang H M, Liao C T and Yen T C 2006 Advantages and pitfalls of 18F-fluoro-2-deoxy-D- glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging Eur. J. Nucl. Med. Mol. Imaging 33 1032-40
18. Chao K S, Bosch W R, Mutic S, Lewis J S, Dehdashti F, Mintun M A, Dempsey J F, Perez C A, Purdy J A and Welch M J 2001 A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 49 1171-82
19. Chatziioannou A F 2002 PET scanners dedicated to molecular imaging of small animal models Mol. Imaging Biol. 4 47-63
20. Cheson B D 2008 New response criteria for lymphomas in clinical trials Ann Oncol. 19 Suppl 4 iv35-8
21. Ciernik I F, Dizendorf E, Baumert B G, Reiner B, Burger C, Davis J B, Lutolf U M, Steinert H C and Von Schulthess G K 2003 Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study Int. J. Radiat. Oncol. Biol. Phys. 57 853-63
22. Connell C A, Corry J, Milner A D, Hogg A, Hicks R J, Rischin D and Peters L J 2007 Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma Head Neck 29 986-95
23. Daisne J F, Duprez T, Weynand B, Lonneux M, Hamoir M, Reychler H and Gregoire V 2004 Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen Radiology 233 93-100
24. Daisne J F, Sibomana M, Bol A, Doumont T, Lonneux M and Gregoire V 2003 Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms Radiother. Oncol. 69 247-50
25. Davis J B, Reiner B, Huser M, Burger C, Szekely G and Ciernik I F 2006 Assessment of 18F PET signals for automatic target volume definition in radiotherapy treatment planning Radiother. Oncol. 80 43-50
26. Dawood M, Buther F, Lang N, Schober O and Schafers K P 2007 Respiratory gating in positron emission tomography: a quantitative comparison of different gating schemes Med. Phys. 34 3067-76
27. de Koste J R, Lagerwaard F J, de Boer H C, Nijssen-Visser M R and Senan S 2003 Are multiple CT scans required for planning curative radiotherapy in lung tumors of the lower lobe? Int. J. Radiat. Oncol. Biol. Phys. 55 1394-9
28. De Ruysscher D et al 2005 Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study Radiother. Oncol. 77 5-10
29. Dehdashti F, Mintun M A, Lewis J S, Bradley J, Govindan R, Laforest R, Welch M J and Siegel B A 2003 In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM Eur. J. Nucl. Med. Mol. Imaging 30 844-50
30. Dierckx R A and Van de Wiele C 2008 FDG uptake, a surrogate of tumour hypoxia? Eur. J. Nucl. Med. Mol. Imaging 35 1544-9
31. Dresel S, Grammerstorff J, Schwenzer K, Brinkbaumer K, Schmid R, Pfluger T and Hahn K 2003 [18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods Eur. J. Nucl. Med. Mol. Imaging 30 995-1003
32. Dwamena B A, Sonnad S S, Angobaldo J O and Wahl R L 1999 Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT Radiology 213 530-6
33. Ekberg L, Holmberg O, Wittgren L, Bjelkengren G and Landberg T 1998 What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother. Oncol. 48 71-7
34. Erdi Y E, Mawlawi O, Larson S M, Imbriaco M, Yeung H, Finn R and Humm J L 1997 Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding Cancer 80 2505-9
35. Eschmann S M, Friedel G, Paulsen F, Reimold M, Hehr T, Scheiderbauer J, Budach W, Kotzerke J and Bares R 2007 Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors Eur. J. Nucl. Med. Mol. Imaging 34 54-9
36. Eschmann S M, Paulsen F, Reimold M, Dittmann H, Welz S, Reischl G, Machulla H J and Bares R 2005 Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy J. Nucl. Med. 46 253-60
37. Evans P M 2008 Topical review: Anatomical imaging for radiotherapy Phys. Med. Biol. 53 R151-91
38. Ford E C, Kinahan P E, Hanlon L, Alessio A, Rajendran J, Schwartz D L and Phillips M 2006 Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes Med. Phys. 33 4280-8
39. Gambhir S S, Czernin J, Schwimmer J, Silverman D H, Coleman R E and Phelps M E 2001 A tabulated summary of the FDG PET literature J. Nucl. Med. 42 1S-93S
40. Geets X, Daisne J F, Gregoire V, Hamoir M and Lonneux M 2004 Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT Radiother. Oncol. 71 267-73
41. Geets X, Lee J A, Bol A, Lonneux M and Gregoire V 2007 A gradient-based method for segmenting FDG-PET images: methodology and validation Eur. J. Nucl. Med. Mol. Imaging 34 1427-38
42. Goerres G W, Kamel E, Heidelberg T N, Schwitter M R, Burger C and von Schulthess G K 2002 PET-CT image co-registration in the thorax: influence of respiration Eur. J. Nucl. Med. Mol. Imaging 29 351-60
43. Goshen E, Davidson T, Yahalom R, Talmi Y P and Zwas S T 2006 PET/CT in the evaluation of patients with squamous cell cancer of the head and neck Int. J. Oral Maxillofac. Surg. 35 332-6
44. Graves E E, Quon A and Loo B W Jr 2007 RT_Image: an open-source tool for investigating PET in radiation oncology Technol. Cancer Res. Treat. 6 111-21
45. Grgic A, U N, Schaefer A, S K, Kirsch C M and Hellwig D 2008 FDG-PET-based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning-an intraindividual comparison Int. J. Radiat. Oncol. Biol. Phys. DOI: 10.1016/j.ijrobp.2008.03.063
46. Grosu A L, Feldmann H, Dick S, Dzewas B, Nieder C, Gumprecht H, Frank A, Schwaiger M, Molls M and Weber W A 2002 Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas Int. J. Radiat. Oncol. Biol. Phys. 54 842-54
47. Grosu A L, Lachner R, Wiedenmann N, Stark S, Thamm R, Kneschaurek P, Schwaiger M, Molls M and Weber W A 2003 Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience Int. J. Radiat. Oncol. Biol. Phys. 56 1450-63
48. Grosu A L et al 2007 Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 69 541-51
49. Grosu A L, Weber W, Feldmann H J, Wuttke B, Bartenstein P, Gross M W, Lumenta C, Schwaiger M and Molls M 2000 First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas Int. J. Radiat. Oncol. Biol. Phys. 47 517-26
50. Grosu A L, Weber W A, Franz M, Stark S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M and Nieder C 2005 Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 63 511-9
51. Grosu A L, Weber W A, Riedel E, Jeremic B, Nieder C, Franz M, Gumprecht H, Jaeger R, Schwaiger M and Molls M 2005 L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 63 64-74
52. Hellwig D, Graeter T P, Ukena D, Groeschel A, Sybrecht G W, Schaefers H J and Kirsch C M 2007 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J. Nucl. Med. 48 1761-6
53. Hentschel M 2007 Möglichkeiten und Grenzen der modernen Schnittbildverfahren (CT, MRT, PET) in der molekularen Bildgebung Der Nuklearmediziner. 30 31-41
54. Hill D L, Batchelor P G, Holden M and Hawkes D J 2001 Medical image registration Phys. Med. Biol. 46 R1-45
55. Humm J L, Rosenfeld A and Del Guerra A 2003 From PET detectors to PET scanners Eur. J. Nucl. Med. Mol. Imaging 30 1574-97
56. ICRU 1999 Prescribing, recording and reporting photon beam therapy. Supplement to report 50
57. ICRU 1993 Prescribing, recording and reporting photon beam therapy
58. Ireland R H, Dyker K E, Barber D C, Wood S M, Hanney M B, Tindale W B, Woodhouse N, Hoggard N, Conway J and Robinson M H 2007 Nonrigid image registration for head and neck cancer radiotherapy treatment planning with PET/CT Int. J. Radiat. Oncol. Biol. Phys. 68 952-7
59. Jaskowiak C J, Bianco J A, Perlman S B and Fine J P 2005 Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values J. Nucl. Med. 46 424-8
60. 18F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer Nucl. Med. Commun. 23 865-70
61. Keall P J, Kini V R, Vedam S S and Mohan R 2001 Motion adaptive x-ray therapy: a feasibility study Phys. Med. Biol. 46 1-10
62. Keall P J et al 2006 The management of respiratory motion in radiation oncology report of AAPM Task Group 76 Med. Phys. 33 3874-900
63. Kirby A M and Mikhaeel N G 2007 The role of FDG PET in the management of lymphoma: what is the evidence base? Nucl. Med. Commun. 28 335-54
64. Kiricuta I C 2001 Selection and delineation of lymph node target volume for lung cancer conformal radiotherapy. Proposal for standardizing terminology based on surgical experience Strahlenther. Onkol. 177 410-23
65. Knight S B, Delbeke D, Stewart J R and Sandler M P 1996 Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy Chest 109 982-8
66. Koh W J et al 1995 Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography Int. J. Radiat. Oncol. Biol. Phys. 33 391-8
67. Koritzinsky M, Seigneuric R, Magagnin M G, van den Beucken T, Lambin P and Wouters B G 2005 The hypoxic proteome is influenced by gene-specific changes in mRNA translation Radiother. Oncol. 76 177-86
68. Kracht L W, Miletic H, Busch S, Jacobs A H, Voges J, Hoevels M, Klein J C, Herholz K and Heiss W D 2004 Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology Clin. Cancer Res. 10 7163-70
69. Langen K J, Ziemons K, Kiwit J C, Herzog H, Kuwert T, Bock W J, Stocklin G, Feinendegen L E and Muller-Gartner H W 1997 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET J. Nucl. Med. 38 517-22
70. Langen K M and Jones D T 2001 Organ motion and its management Int. J. Radiat. Oncol. Biol. Phys. 50 265-78
71. Lee N Y et al 2008 Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study Int. J. Radiat. Oncol. Biol. Phys. 70 2-13
72. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U and Joensuu H 1993 Influence of the blood glucose concentration on FDG uptake in cancer-a PET study J. Nucl. Med. 34 1-6
73. Ling C C, Humm J, Larson S, Amols H, Fuks Z, Leibel S and Koutcher J A 2000 Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality Int. J. Radiat. Oncol. Biol. Phys. 47 551-60
74. Ling C C, Yorke E, Amols H, Mechalakos J, Erdi Y, Leibel S, Rosenzweig K and Jackson A 2004 High-tech will improve radiotherapy of NSCLC: a hypothesis waiting to be validated Int. J. Radiat. Oncol. Biol. Phys. 60 3-7
75. Liu T, Xu W, Yan W L, Ye M, Bai Y R and Huang G 2007 FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review Radiother. Oncol. 85 327-35
76. Livieratos L, Rajappan K, Stegger L, Schafers K, Bailey D L and Camici P G 2006 Respiratory gating of cardiac PET data in list-mode acquisition Eur. J. Nucl. Med. Mol. Imaging 33 584-8
77. MacManus M P, Bayne M, Fimmell N, Reynolds J, Everitt S, Ball D, Pitman A, Ware R, Lau E and R H 2007 Reproducibility of "Intelligent" Contouring of Gross Tumor Volume in Non-Small Cell Lung Cancer on PET/CT Images Using a Standardized Visual Method Internat J. Radiat. Oncol. Biol. Phys. 69 S154-5
78. MacManus M P and Hicks R J 2008 Where do we draw the line? Contouring tumors on positron emission tomography/computed tomography Int. J. Radiat. Oncol. Biol. Phys. 71 2-4
79. MacManus M P, Hicks R J, Matthews J P, Hogg A, McKenzie A F, Wirth A, Ware R E and Ball D L 2001 High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 50 287-93
80. Madani I et al 2007 Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 68 126-35
81. Menda Y, Bushnell D L, Madsen M T, McLaughlin K, Kahn D and Kernstine K H 2001 Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy Nucl. Med. Commun. 22 1077-81
82. Milker-Zabel S, Zabel-du Bois A, Henze M, Huber P, Schulz-Ertner D, Hoess A, Haberkorn U and Debus J 2006 Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET Int. J. Radiat. Oncol. Biol. Phys. 65 222-7
83. Miwa K et al 2008 Simultaneous integrated boost technique by helical tomotherapy for the treatment of glioblastoma multiforme with 11C-methionine PET: report of three cases J. Neurooncol. 87 333-9
84. Mix M and Kremp S 2008 PET in der Strahlentherapie: Zielvolumen Der Nuklearmediziner. in press
85. Muehllehner G and Karp J S 2006 Positron emission tomography Phys. Med. Biol. 51 R117-37
86. Munley M T, Marks L B, Scarfone C, Sibley G S, Patz E F Jr, Turkington T G, Jaszczak R J, Gilland D R, Anscher M S and Coleman R E 1999 Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects Lung Cancer 23 105-14
87. Nakamoto Y, Tatsumi M, Hammoud D, Cohade C, Osman M M and Wahl R L 2005 Normal FDG distribution patterns in the head and neck: PET/CT evaluation Radiology 234 879-85
88. Nehmeh S A, Erdi Y E, Ling C C, Rosenzweig K E, Schoder H, Larson S M, Macapinlac H A, Squire O D and Humm J L 2002 Effect of respiratory gating on quantifying PET images of lung cancer J. Nucl. Med. 43 876-81
89. Nehmeh S A et al 2004 Four-dimensional (4D) PET/CT imaging of the thorax Med. Phys. 31 3179-86
90. Nehmeh S A et al 2008 Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 70 235-42
91. Nestle U, Hellwig D, Schmidt S, Licht N, Walter K, Ukena D, Rübe C, Baumann M and Kirsch C M 2002 2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer Mol. Imaging Biol. 4 257-63
92. Nestle U, Kremp S and Grosu A 2006 Practical integration of [(18)F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives Radiother. Oncol. 81 209-225
93. Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C and Kirsch C M 2005 Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer J. Nucl. Med. 46 1342-8
94. Nestle U, Schaefer-Schuler A, Kremp S, Groeschel A, Hellwig D, Rube C and Kirsch C M 2007 Target volume definition for (18)F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer Eur. J. Nucl. Med. Mol. Imaging 34 453-462
95. Nestle U et al 1999 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis Int. J. Radiat. Oncol. Biol. Phys. 44 593-7
96. Nishioka T et al 2002 Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas Int. J. Radiat. Oncol. Biol. Phys. 53 1051-7
97. Nordsmark M et al 2005 Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother. Oncol. 77 18-24
98. Nutt R 2002 The history of Positron emission tomography Mol. Imaging Biol. 4 11-26
99. 18F-FDG: standardized uptake values in normal tissues J. Nucl. Med. 45 784-8
100. Park S J, Ionascu D, Killoran J, Mamede M, Gerbaudo V H, Chin L and Berbeco R 2008 Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images Phys. Med. Biol. 53 3661-79
101. Paulino A C and Johnstone P A 2004 FDG-PET in radiotherapy treatment planning: Pandora's box? Int. J. Radiat. Oncol. Biol. Phys. 59 4-5
102. Paulino A C, Koshy M, Howell R, Schuster D and Davis L W 2005 Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer Int. J. Radiat. Oncol. Biol. Phys. 61 1385-92
103. Plathow C and Weber W A 2008 Tumor cell metabolism imaging J. Nucl. Med. 49 (Suppl 2) 43S-63S
104. Plotkin M, Gneveckow U, Meier-Hauff K, Amthauer H, Feussner A, Denecke T, Gutberlet M, Jordan A, Felix R and Wust P 2006 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma Int. J. Hyperthermia. 22 319-25
105. Ponisch F, Richter C, Just U and Enghardt W 2008 Attenuation correction of four dimensional (4D) PET using phase-correlated 4D-computed tomography Phys. Med. Biol. 53 N259-68
106. Pötzsch C, Hofheinz F and van den Hoff J 2006 Vergleich der Inter-Observer-Variabilität bei manueller und automatischer Volumenbestimmung in der PET Nuklearmedizin 45 A42
107. Rahn A N, Baum R P, Adamietz I A, Adams S, Sengupta S, Mose S, Bormeth S B, Hor G and Bottcher H D 1998 Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors Strahlenther Onkol. 174 358-64
108. Rasey J S, Koh W J, Evans M L, Peterson L M, Lewellen T K, Graham M M and Krohn K A 1996 Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients Int. J. Radiat. Oncol. Biol. Phys. 36 417-28
109. Rosenzweig K E et al 2000 The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer Int. J. Radiat. Oncol. Biol. Phys. 48 81-7
110. Rosenzweig K E, Sura S, Jackson A and Yorke E 2007 Involved-field radiation therapy for inoperable non small-cell lung cancer J. Clin. Oncol.
111. Ross C S, Hussey D H, Pennington E C, Stanford W and Doornbos J F 1990 Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography Int. J. Radiat. Oncol. Biol. Phys. 18 671-7
112. Sanchez-Crespo A, Andreo P and Larsson S A 2004 Positron flight in human tissues and its influence on PET image spatial resolution Eur. J. Nucl. Med. Mol. Imaging 31 44-51
113. Scarfone C, Lavely W C, Cmelak A J, Delbeke D, Martin W H, Billheimer D and Hallahan D E 2004 Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging J. Nucl. Med. 45 543-52
114. Schaefer A, Kremp S, Hellwig D, Rube C and Kirsch C M 2008 Target volumes derived from FDG-PET in lung cancer: Phantom measurements for delineation of contours Eur. J. Nucl. Med. in press
115. Schinagl D A, Vogel W V, Hoffmann A L, van Dalen J A, Oyen W J and Kaanders J H 2007 Comparison of five segmentation tools for 18F-fluoro-deoxy- glucose-positron emission tomography-based target volume definition in head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 69 1282-9
116. Schoder H et al 2006 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI J. Nucl. Med. 47 755-62
117. Schoder H, Erdi Y E, Chao K, Gonen M, Larson S M and Yeung H W 2004 Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients J. Nucl. Med. 45 559-66
118. Schwartz D L et al 2005 FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma Int. J. Radiat. Oncol. Biol. Phys. 61 129-36
119. Senan S, Chapet O, Lagerwaard F J and Ten Haken R K 2004 Defining target volumes for non-small cell lung carcinoma Semin. Radiat. Oncol. 14 308-14
120. Senan S, De Ruysscher D, Giraud P, Mirimanoff R and Budach V 2004 Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer Radiother. Oncol. 71 139-46
121. Shields A F, Grierson J R, Dohmen B M, Machulla H J, Stayanoff J C, Lawhorn-Crews J M, Obradovich J E, Muzik O and Mangner T J 1998 Imaging proliferation in vivo with [F-18]FLT and positron emission tomography Nat. Med. 4 1334-6
122. Shirato H, Seppenwoolde Y, Kitamura K, Onimura R and Shimizu S 2004 Intrafractional tumor motion: lung and liver Semin. Radiat. Oncol. 14 10-8
123. Steenbakkers R J et al 2006 Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis Int. J. Radiat. Oncol. Biol. Phys. 64 435-48
124. Sura S, Greco C, Gelblum D, Yorke E D, Jackson A and Rosenzweig K E 2008 (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 70 1397-402
125. Tanderup K, Olsen D R and Grau C 2006 Dose painting: Art or science? Radiother. Oncol. 79 245-8
126. Tarantola G, Zito F and Gerundini P 2003 PET Instrumentation and Reconstruction Algorithms in Whole-Body Applications J. Nucl. Med. 44 756-769
127. Troost E G, Bussink J, Kaanders J H, van Eerd J, Peters J P, Rijken P F, Boerman O C and van der Kogel A J 2005 Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines Radiother. Oncol. 76 194-9
128. Van de Steene J, Linthout N, de Mey J, Vinh-Hung V, Claassens C, Noppen M, Bel A and Storme G 2002 Definition of gross tumor volume in lung cancer: inter-observer variability Radiother. Oncol. 62 37-49
129. van Tinteren H et al 2002 Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 1388-93
130. Visvikis D and Ell P J 2003 Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives Eur. J. Nucl. Med. Mol. Imaging 30 (Suppl 1) S106-16
131. von Schulthess G K, Steinert H C and Hany T F 2006 Integrated PET/CT: current applications and future directions Radiology 238 405-22
132. Weber W A, Dick S, Reidl G, Dzewas B, Busch R, Feldmann H J, Molls M, Lumenta C B, Schwaiger M and Grosu A L 2001 Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas J. Nucl. Med. 42 1144-50
133. Weber W A, Grosu A L and Czernin J 2008 Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning Nat. Clin. Pract. Oncol. 5 160-70
134. Weber W A, Wester H J, Grosu A L, Herz M, Dzewas B, Feldmann H J, Molls M, Stocklin G and Schwaiger M 2000 O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study Eur J. Nucl. Med. 27 542-9
135. Wieler H J and Coleman R E 2000 PET in clinical oncology
136. Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U and Heiss W D 1992 Performance evaluation of the positron scanner ECAT EXACT J. Comput. Assist. Tomogr. 16 804-13
137. Wienhard K, Wagner R and Heiss W D 1989 PET Grundlagen und Anwendungen der Positronen Emissions Tomographie
138. Williams K J et al 2005 Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1 Radiother. Oncol. 75 89-98
139. Yap C S, Czernin J, Fishbein M C, Cameron R B, Schiepers C, Phelps M E and Weber W A 2006 Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography Chest 129 393-401
140. Yaromina A, Holscher T, Eicheler W, Rosner A, Krause M, Hessel F, Petersen C, Thames H D, Baumann M and Zips D 2005 Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma? Radiother. Oncol. 76 206-12
141. Zhang T, Jeraj R, Keller H, Lu W, Olivera G H, McNutt T R, Mackie T R and Paliwal B 2004 Treatment plan optimization incorporating respiratory motion Med. Phys. 31 1576-86
142. Zimny M, Hochstenbag M, Lamers R, Reinartz P, Cremerius U, Ten Velde G and Büll U 2003 Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera Eur. Radiol. 13 740-7